Metal-organic framework-coated magnetite nanoparticles for synergistic magnetic hyperthermia and chemotherapy with pH-triggered drug release

In nanoplatform-based tumor treatment, combining chemotherapy with hyperthermia therapy is an interesting strategy to achieve enhanced therapeutic efficacy with low dose of delivery drugs. Compared to photothermal therapy, magnetic hyperthermia has few restrictions on penetrating tissue by an altern...

Full description

Bibliographic Details
Main Authors: Jiajie Chen, Jiaxing Liu, Yaping Hu, Zhengfang Tian, Yufang Zhu
Format: Article
Language:English
Published: Taylor & Francis Group 2019-12-01
Series:Science and Technology of Advanced Materials
Subjects:
Online Access:http://dx.doi.org/10.1080/14686996.2019.1682467
id doaj-b8930e7208b147d38ff667752fd010a7
record_format Article
spelling doaj-b8930e7208b147d38ff667752fd010a72020-11-25T03:45:56ZengTaylor & Francis GroupScience and Technology of Advanced Materials1468-69961878-55142019-12-012011043105410.1080/14686996.2019.16824671682467Metal-organic framework-coated magnetite nanoparticles for synergistic magnetic hyperthermia and chemotherapy with pH-triggered drug releaseJiajie Chen0Jiaxing Liu1Yaping Hu2Zhengfang Tian3Yufang Zhu4University of Shanghai for Science and TechnologyUniversity of Shanghai for Science and TechnologyUniversity of Shanghai for Science and TechnologyHuanggang Normal UniversityUniversity of Shanghai for Science and TechnologyIn nanoplatform-based tumor treatment, combining chemotherapy with hyperthermia therapy is an interesting strategy to achieve enhanced therapeutic efficacy with low dose of delivery drugs. Compared to photothermal therapy, magnetic hyperthermia has few restrictions on penetrating tissue by an alternating magnetic field, and thereby could cure various solid tumors, even deep-tissue ones. In this work, we proposed to construct magnetic nanocomposites (Fe3O4@PDA@ZIF-90) by the external growth of metal-organic framework ZIF-90 on polydopamine (PDA)-coated Fe3O4 nanoparticles for synergistic magnetic hyperthermia and chemotherapy. In such multifunctional platform, Fe3O4 nanoparticle was utilized as a magnetic heating seed, PDA layer acted as an inducer for the growth of ZIF-90 shell and porous ZIF-90 shell served as drug nanocarrier to load doxorubicin (DOX). The well-defined Fe3O4@PDA@ZIF-90 core-shell nanoparticles were displayed with an average size of ca. 200 nm and possessed the abilities to load high capacity of DOX as well as trigger drug release in a pH-responsive way. Furthermore, the Fe3O4@PDA@ZIF-90 nanoparticles can raise the local temperature to meet hyperthermia condition under an alternating magnetic field owing to the magnetocaloric effect of Fe3O4 cores. In the in vitro experiments, the Fe3O4@PDA@ZIF-90 nanoparticles showed a negligible cytotoxicity to Hela cells. More significantly, after cellular internalization, the DOX-loaded Fe3O4@PDA@ZIF-90 nanoparticles exhibited distinctively synergistic effect to kill tumor cells with higher efficacy compared to chemotherapy or magnetic hyperthermia alone, presenting a great potential for efficient tumor therapy.http://dx.doi.org/10.1080/14686996.2019.1682467multifunctional nanoparticlesmetal-organic frameworksmagnetic hyperthermiachemotherapysynergistic effect
collection DOAJ
language English
format Article
sources DOAJ
author Jiajie Chen
Jiaxing Liu
Yaping Hu
Zhengfang Tian
Yufang Zhu
spellingShingle Jiajie Chen
Jiaxing Liu
Yaping Hu
Zhengfang Tian
Yufang Zhu
Metal-organic framework-coated magnetite nanoparticles for synergistic magnetic hyperthermia and chemotherapy with pH-triggered drug release
Science and Technology of Advanced Materials
multifunctional nanoparticles
metal-organic frameworks
magnetic hyperthermia
chemotherapy
synergistic effect
author_facet Jiajie Chen
Jiaxing Liu
Yaping Hu
Zhengfang Tian
Yufang Zhu
author_sort Jiajie Chen
title Metal-organic framework-coated magnetite nanoparticles for synergistic magnetic hyperthermia and chemotherapy with pH-triggered drug release
title_short Metal-organic framework-coated magnetite nanoparticles for synergistic magnetic hyperthermia and chemotherapy with pH-triggered drug release
title_full Metal-organic framework-coated magnetite nanoparticles for synergistic magnetic hyperthermia and chemotherapy with pH-triggered drug release
title_fullStr Metal-organic framework-coated magnetite nanoparticles for synergistic magnetic hyperthermia and chemotherapy with pH-triggered drug release
title_full_unstemmed Metal-organic framework-coated magnetite nanoparticles for synergistic magnetic hyperthermia and chemotherapy with pH-triggered drug release
title_sort metal-organic framework-coated magnetite nanoparticles for synergistic magnetic hyperthermia and chemotherapy with ph-triggered drug release
publisher Taylor & Francis Group
series Science and Technology of Advanced Materials
issn 1468-6996
1878-5514
publishDate 2019-12-01
description In nanoplatform-based tumor treatment, combining chemotherapy with hyperthermia therapy is an interesting strategy to achieve enhanced therapeutic efficacy with low dose of delivery drugs. Compared to photothermal therapy, magnetic hyperthermia has few restrictions on penetrating tissue by an alternating magnetic field, and thereby could cure various solid tumors, even deep-tissue ones. In this work, we proposed to construct magnetic nanocomposites (Fe3O4@PDA@ZIF-90) by the external growth of metal-organic framework ZIF-90 on polydopamine (PDA)-coated Fe3O4 nanoparticles for synergistic magnetic hyperthermia and chemotherapy. In such multifunctional platform, Fe3O4 nanoparticle was utilized as a magnetic heating seed, PDA layer acted as an inducer for the growth of ZIF-90 shell and porous ZIF-90 shell served as drug nanocarrier to load doxorubicin (DOX). The well-defined Fe3O4@PDA@ZIF-90 core-shell nanoparticles were displayed with an average size of ca. 200 nm and possessed the abilities to load high capacity of DOX as well as trigger drug release in a pH-responsive way. Furthermore, the Fe3O4@PDA@ZIF-90 nanoparticles can raise the local temperature to meet hyperthermia condition under an alternating magnetic field owing to the magnetocaloric effect of Fe3O4 cores. In the in vitro experiments, the Fe3O4@PDA@ZIF-90 nanoparticles showed a negligible cytotoxicity to Hela cells. More significantly, after cellular internalization, the DOX-loaded Fe3O4@PDA@ZIF-90 nanoparticles exhibited distinctively synergistic effect to kill tumor cells with higher efficacy compared to chemotherapy or magnetic hyperthermia alone, presenting a great potential for efficient tumor therapy.
topic multifunctional nanoparticles
metal-organic frameworks
magnetic hyperthermia
chemotherapy
synergistic effect
url http://dx.doi.org/10.1080/14686996.2019.1682467
work_keys_str_mv AT jiajiechen metalorganicframeworkcoatedmagnetitenanoparticlesforsynergisticmagnetichyperthermiaandchemotherapywithphtriggereddrugrelease
AT jiaxingliu metalorganicframeworkcoatedmagnetitenanoparticlesforsynergisticmagnetichyperthermiaandchemotherapywithphtriggereddrugrelease
AT yapinghu metalorganicframeworkcoatedmagnetitenanoparticlesforsynergisticmagnetichyperthermiaandchemotherapywithphtriggereddrugrelease
AT zhengfangtian metalorganicframeworkcoatedmagnetitenanoparticlesforsynergisticmagnetichyperthermiaandchemotherapywithphtriggereddrugrelease
AT yufangzhu metalorganicframeworkcoatedmagnetitenanoparticlesforsynergisticmagnetichyperthermiaandchemotherapywithphtriggereddrugrelease
_version_ 1724508852320206848